SIRT2-IN-11 (AEM1) is a selective SIRT2 inhibitor with an IC 50 value of 18.5 μM. SIRT2-IN-11 p53-dependently induces apoptosis , activates expression of CDKN1A , PUMA and NOXA , and increases acetylation of p53. SIRT2-IN-11 can be used for the research of p53-related cancers.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Sirtuin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.